Franko BURČUL, Ivana ŠAGUD, Irena ŠKORIĆ, Ana RATKOVIĆ, Dragana VUK

Acetyl- and butyrylcholinesterase inhibitory activity of selected photochemically synthesized polycycles

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the main cause of dementiain the elderly population. Since the treatment of AD has been associated with the activity of acetylcholinesterase(AChE) and butyrylcholinesterase (BChE), their inhibitors remain the main focus of AD investigations. In this study we evaluated cholinesterase inhibitory activity of 14 bicyclo[3.2.1]octene/octadiene derivatives and naturally occurring sesquiterpene alcohol cedrol. These 14 compounds have been efficiently and ecologically prepared by a photochemical approach in batch photochemical reactors. Various compounds with the bicyclo[3.2.1]octene skeleton have already been successfully evaluated for treatment of central nervous system disorders and AD. Among the tested polycyclic derivatives, compounds 4-[(9S)-tricyclo[6.3.1.0 2,7 ]dodeca-2,4,6,10-tetraen-9-yl]pyridine (3) and (11S)-11-(4-chlorophenyl)-12-[(E)- 2-(4 chlorophenyl)ethenyl]tricyclo[6.3.1.0 2,7 ]dodeca-2,4,6,9-tetraene (6) showed the best inhibitory activity on BChE (IC50 = 8.8 µM) and AChE (IC50 = 17.5 µM), respectively.

PDF

___

1. Kukull WA, Higdon R, Bowen JD, McCormick WC, Teri L et al. Dementia and Alzheimer disease incidence: a prospective cohort study. Archives of Neurology 2002; 59 (11): 1737-1746. doi: 10.1001/archneur.59.11.1737
2. Tarawneh R. Holtzman DM. The clinical problem of symptomatic alzheimer disease and mild cognitive impairment. Cold Spring Harbor Perspectives in Medicine 2012; 2 (5): 1-16. doi: 10.1101/cshperspect.a006148
3. Khan MTH. Molecular interactions of cholinesterases inhibitors using in silico methods: current status and future prospects. New Biotechnology 2009; 25 (5): 331-346. doi: https://doi.org/10.1016/j.nbt.2009.03.008
4. Masson P, Carletti E, Nachon F. Structure, activities and biomedical applications of human butyrylcholinesterase. Protein and Peptide Letters 2009; 16 (10): 1215-1224. doi: http://dx.doi.org/10.2174/092986609789071207
5. Öztaskın N, Taslimi P, Maraş A, Gülcin İ. Göksu S. Novel antioxidant bromophenols with acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase inhibitory actions. Bioorganic Chemistry 2017; 74: 104-114. doi: https://doi.org/10.1016/j.bioorg.2017.07.010
6. Akıncıoğlu A, Kocaman E, Akıncıoğlu H, Salmas RE, Durdagi S et al. The synthesis of novel sulfamides derived from β -benzylphenethylamines as acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase enzymes inhibitors. Bioorganic Chemistry 2017; 74: 238-250. doi: https://doi.org/10.1016/j.bioorg.2017.08.012
7. Burčul F, Radan M, Politeo O. Blažević I. Cholinesterase-inhibitory activity of essential oils. In: Taylor JC (editor). Advances in Chemistry Research. New York, NY, USA: Nova Science Publishers Inc., 2017, pp. 1-71.
8. Gulçin İ, Abbasova M, Taslimi P, Huyut Z, Safarova L et al. Synthesis and biological evaluation of aminomethyl and alkoxymethyl derivatives as carbonic anhydrase, acetylcholinesterase and butyrylcholinesterase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 2017; 32 (1): 1174-1182. doi: 10.1080/14756366.2017.1368019
9. Greig NH, Utsuki T, Ingram DK, Wang Y, Pepeu G et al. Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β -amyloid peptide in rodent. Proceedings of the National Academy of Sciences of the United States of America 2005; 102 (47): 17213-17218. doi: 10.1073/pnas.0508575102
10. Giacobini E. Cholinesterase inhibitors: new roles and therapeutic alternatives. Pharmacological Research 2004; 50 (4): 433-440. doi: https://doi.org/10.1016/j.phrs.2003.11.017
11. Nicolet Y, Lockridge O, Masson P, Fontecilla-Camps JC, Nachon F. Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products. Journal of Biological Chemistry 2003; 278 (42): 41141-41147. doi: 10.1074/jbc.M210241200
12. Dvir H, Silman I, Harel M, Rosenberry TL. Sussman JL. Acetylcholinesterase: from 3D structure to function. Chemico-Biological Interactions 2010; 187 (1): 10-22. doi: https://doi.org/10.1016/j.cbi.2010.01.042
13. Abad A, Agulló C, Cuñat A, De Alfonso I, Navarro I et al. Synthesis of highly functionalised enantiopure bicyclo[3.2.1]-octane systems from carvone. Molecules 2004; 9 (5): 287-299.
14. Miller JA, Harris J, Miller AA, Ullah GM, Welsh GM. Synthesis of 8-substituted bicyclo[3.2.1]octane-6-carboxylic acids and anti-convulsant properties of the corresponding amides. Tetrahedron Letters 2004; 45 (22): 4323-4327. doi: https://doi.org/10.1016/j.tetlet.2004.04.007
15. Thomson CG, Carlson E, Chicchi GG, Kulagowski JJ, Kurtz MM et al. Synthesis and structure–activity relationships of 8-azabicyclo[3.2.1]octane benzylamine NK1 antagonists. Bioorganic & Medicinal Chemistry Letters 2006; 16 (4): 811-814. doi: https://doi.org/10.1016/j.bmcl.2005.11.026
16. Mascitti V. Préville C. Stereoselective synthesis of a dioxa-bicyclo[3.2.1]octane SGLT2 inhibitor. Organic Letters 2010; 12 (13): 2940-2943. doi: 10.1021/ol100940w
17. Kavitha CV, Nambiar M, Narayanaswamy PB, Thomas E, Rathore U et al. Propyl-2-(8-(3,4-difluorobenzyl)-2′ ,5′-dioxo-8-azaspiro[bicyclo[3.2.1] octane-3,4′ -imidazolidine]-1′ -yl) acetate induces apoptosis in human leukemia cellsthrough mitochondrial pathway following cell cycle arrest. PLoS One 2013; 8 (7): e69103. doi: 10.1371/journal.pone.0069103
18. Kraus GA, Hon YS, Sy J. Synthesis of bicyclo[3.2.1]octanes by ring contraction. Journal of Organic Chemistry 1986; 51 (14): 2625-2627. doi: 10.1021/jo00364a001
19. Filippini MH, Rodriguez J. Synthesis of functionalized bicyclo[3.2.1]octanes and their multiple uses in organic chemistry. Chemical Reviews 1999; 99 (1): 27-76. doi: 10.1021/cr970029u
20. Presset M, Coquerel Y, Rodriguez J. Syntheses and applications of functionalized bicyclo[3.2.1]octanes: thirteen years of progress. Chemical Reviews 2013; 113 (1): 525-595. doi: 10.1021/cr200364p
21. Meltzer PC, Blundell P, Yong YF, Chen Z, George C et al. 2-Carbomethoxy-3-aryl-8-bicyclo[3.2.1]octanes: potent non-nitrogen inhibitors of monoamine transporters. Journal of Medicinal Chemistry 2000; 43 (16): 2982-2991. doi: 10.1021/jm000191g
22. Mandzhulo AY, Mel’nichuk NA, Fetyukhin VN, Vovk MV. Synthesis of 4′ -alkyl-8-azaspiro[bicyclo[3.2.1]octane3,2′ -morpholin]-5′ -ones. Russian Journal of Organic Chemistry 2016; 52 (1): 87-91. doi: 10.1134/S1070428016010164
23. Klumpp GW, Barnick JWFK, Veefkind AH, Bickelhaupt F. The synthesis of substituted bicyclo[3.2.1]octa-2,6- dienes. Recueil des Travaux Chimiques des Pays-Bas 1969; 88 (7): 766-778. doi: doi:10.1002/recl.19690880702
24. Nitta M, Okada S, Kato M. Stereoelectronic and homoconjugative effect of stereoselectivity. The addition of dichlorocarbene to 1,5-dimethyl-6-methylenetricyclo[3.2.1.02,7]oct-3-en-8-one and its related compounds. Bulletin of the Chemical Society of Japan 1984; 57 (9): 2463-2467. doi: 10.1246/bcsj.57.2463
25. Jones PS, Smith PW, Hardy GW, Howes PD, Upton RJ et al. Synthesis of tetrasubstituted bicyclo[3.2.1]octenes as potential inhibitors of influenza virus sialidase. Bioorganic and Medicinal Chemistry Letters 1999; 9 (4): 605-610. doi: https://doi.org/10.1016/S0960-894X(99)00032-3
26. Sakata J, Ando Y, Ohmori K, Suzuki K. Synthetic study on naphthospironone A: construction of benzobicyclo[3.2.1]octene skeleton with oxaspirocycle. Organic Letters 2015; 17 (15): 3746-3749. doi: 10.1021/acs.orglett.5b01732
27. Su X, Sun Y, Yao J, Chen H, Chen C. Acid-promoted bicyclization of arylacetylenes to benzobicyclo[3.2.1]octanes through cationic rearrangements. Chemical Communications 2016; 52 (24): 4537-4540. doi: 10.1039/C6CC00452K
28. Šindler-Kulyk M, Špoljarić L, Marinić Ž. Photochemistry of β -(2-furyl) substituted o-divinylbenzenes. Heterocycles 1989; 29 (4): 679-682. doi: 10.3987/COM-89-4629
29. Šindler-Kulyk M, Tomšić S, Marinić Ž, Metelko B. Synthesis and photochemistry of 2-styrylpyrroles. Intermolecular photoaddition of pyrroles to a double bond. Recueil des Travaux Chimiques des Pays-Bas 1995; 114 (11-12): 476- 479. doi: doi:10.1002/recl.19951141109
30. Sindler-Kulyk M, Skoric I, Tomsic S, Marinic Z, Mrvos-Sermek D. Synthesis and photochemistry of styryl substituted annelated furan derivatives. Heterocycles 1999; 51 (6): 1355-1369. doi: 10.3987/COM-99-8502
31. Škorić I, Basarić N, Marinić Z, Šindler-Kulyk M. Observation of the primary intermediates in the photochemistry of o-vinylstyrylfurans. Heterocycles 2001; 55 (10): 1889-1896. doi: 10.3987/COM-01-9314
32. Basarić N, Marinić Ž, Šindler-Kulyk M. Photochemical formation of novel pyrrolo[3,2-b]-6,7-benzobicyclo[3.2.1]octa2,6-diene. Journal of Organic Chemistry 2003; 68 (19): 7524-7527. doi: 10.1021/jo0346454
33. Škorić I, Basarić N, Marinić Ž, Višnjevac A, Kojić-Prodić B et al. Synthesis and photochemistry of β ,β ′-di(2-furyl)- substituted o-divinylbenzenes: intra- and/or intermolecular cycloaddition as an effect of annelation. Chemistry-A European Journal 2005; 11 (2): 543-551. doi: doi:10.1002/chem.200401005
34. Škorić I, Flegar I, Marinić Ž, Šindler-Kulyk M. Synthesis of the novel conjugated ω,ω ′ -diaryl/heteroaryl hexatriene system with the central double bond in a heteroaromatic ring: photochemical transformations of 2,3-divinylfuran derivatives. Tetrahedron 2006; 62 (31): 7396-7407. doi: https://doi.org/10.1016/j.tet.2006.05.034
35. Vidaković D, Škorić I, Horvat M, Marinić Ž, Šindler-Kulyk M. Photobehaviour of 2- and 3-heteroaryl substituted o-divinylbenzenes; formation of fused 2,3- and 3,2-heteroareno-benzobicyclo[3.2.1]octadienes and 3-heteroaryl benzobicyclo[2.1.1]hexenes. Tetrahedron 2008; 64 (18): 3928-3934. doi: https://doi.org/10.1016/j.tet.2008.02.062
36. Škorić I, Šmehil M, Marinić Ž, Molčanov K, Kojić-Prodić B et al. Photochemistry of ω-(o-vinylphenyl)-ω′- (phenyl/2-furyl) butadienes: new approach to 4-substituted benzobicyclo[3.2.1]octadienes. Journal of Photochemistry and Photobiology A: Chemistry 2009; 207 (2): 190-196. doi: https://doi.org/10.1016/j.jphotochem.2009.07.008
37. Kikaš I, Škorić I, Marinić Ž, Šindler-Kulyk M. Synthesis and phototransformations of novel styryl-substituted furo-benzobicyclo[3.2.1]octadiene derivatives. Tetrahedron 2010; 66 (48): 9405-9414. doi: https://doi.org/10.1016/ j.tet.2010.09.093
38. Kikaš I, Horváth O, Škorić I. Functionalization of the benzobicyclo[3.2.1]octadiene skeleton via photocatalytic and thermal oxygenation of a furan derivative. Tetrahedron Letters 2011; 52 (47): 6255-6259. doi: https://doi.org/10.1016/ j.tetlet.2011.09.076
39. Škorić I, Kikaš I, Kovács M, Fodor L, Marinić Ž et al. Synthesis, photochemistry, and photophysics of butadiene derivatives: influence of the methyl group on the molecular structure and photoinduced behavior. Journal of Organic Chemistry 2011; 76 (21): 8641-8657. doi: 10.1021/jo200691x
40. Kikaš I, Horváth O, Škorić I. Functionalization of the benzobicyclo[3.2.1]octadiene skeleton via photocatalytic oxygenation of furan and benzofuran derivatives. Journal of Molecular Structure 2013; 1034: 62-68. doi: https://doi.org/ 10.1016/j.molstruc.2012.09.005
41. Vuk D, Potroško D, Šindler-Kulyk M, Marinić Ž, Molčanov K et al. Synthesis and photochemical transformations of new butadiene chromophores: the influence of the nature and position of chlorine substituent on the photoinduced behaviour. Journal of Molecular Structure 2013; 1051: 1-14. doi: https://doi.org/10.1016/j.molstruc.2013.07.052
42. Vuk D, Kikaš I, Molčanov K, Horváth O, Škorić I. Functionalization of the benzobicyclo[3.2.1]octadiene skeleton via photocatalytic oxygenation of thiophene and furan derivatives: the impact of the type and position of the heteroatom. Journal of Molecular Structure 2014; 1063: 83-91. doi: https://doi.org/10.1016/j.molstruc.2014.01.055
43. Vuk D, Marinić Ž. Škorić I. Photochemical approach to new polycyclic substrates suitable for further photocatalytic functionalization. Croatica Chemica Acta 2014; 87 (4): 465-473. doi: 10.5562/cca2454
44. Vuk D, Horváth O, Marinić Ž, Škorić I. Functionalization of the benzobicyclo[3.2.1] octadiene skeleton possessing one isolated double bond via photocatalytic oxygenation. Journal of Molecular Structure 2016; 1107: 70-76. doi: https://doi.org/10.1016/j.molstruc.2015.11.036
45. Šagud I, Levačić M, Marinić Ž, Škorić I. Formation of polycyclic skeletons by photochemical transformations of pyridyl- and thienylbutadiene derivatives. European Journal of Organic Chemistry 2017; 2017 (26): 3787-3794. doi: doi:10.1002/ejoc.201700481
46. Miyazawa M, Yamafuji C. Inhibition of acetylcholinesterase activity by bicyclic monoterpenoids. Journal of Agricultural and Food Chemistry 2005; 53 (5): 1765-1768. doi: 10.1021/jf040019b
47. Greenblatt HM, Kryger G, Lewis T, Silman I, Sussman JL. Structure of acetylcholinesterase complexed with (–)- galanthamine at 2.3 Å resolution. FEBS Letters 1999; 463 (3): 321-326. doi: doi:10.1016/S0014-5793(99)01637-3
48. Bai D. Development of huperzine A and B for treatment of Alzheimer’s disease. Pure and Applied Chemistry 2007; 79 (4): 469-479. doi: 10.1351/pac200779040469
49. Haigh JR, Johnston SR, Peppernay A, Mattern PJ, Garcia GE et al. Protection of red blood cell acetylcholinesterase by oral huperzine A against ex vivo soman exposure: next generation prophylaxis and sequestering of acetylcholinesterase over butyrylcholinesterase. Chemico-Biological Interactions 2008; 175 (1): 380-386. doi: https://doi.org/10.1016/j.cbi.2008.04.033
50. Lockridge O. Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses. Pharmacology and Therapeutics 2015; 148: 34-46. doi: https://doi.org/10.1016/ j.pharmthera.2014.11.011
51. Tang XC, Han YF. Pharmacological profile of huperzine A, a novel acetylcholinesterase inhibitor from Chinese herb. CNS Drug Reviews 1999; 5 (3): 281-300. doi: 10.1111/j.1527-3458.1999.tb00105.x
52. Wang R, Yan H, Tang XC. Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine. Acta Pharmacologica Sinica 2006; 27: 1-26. doi: 10.1111/j.1745-7254.2006.00255.x
53. Testa B, Crivori P, Reist M, Carrupt PA. The influence of lipophilicity on the pharmacokinetic behavior of drugs: concepts and examples. Perspectives in Drug Discovery and Design 2000; 19 (1): 179-211. doi: 10.1023/a:1008741731244
54. Alavijeh MS, Chishty M, Qaiser MZ, Palmer AM. Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery. NeuroRx 2005; 2 (4): 554-571. doi: 10.1602/neurorx.2.4.554
55. Pajouhesh H, Lenz GR. Medicinal chemical properties of successful central nervous system drugs. NeuroRx 2005; 2 (4): 541-553. doi: 10.1602/neurorx.2.4.541
56. Gurjar AS, Darekar MN, Yeong KY, Ooi L. In silico studies, synthesis and pharmacological evaluation to explore multi-targeted approach for imidazole analogues as potential cholinesterase inhibitors with neuroprotective role for Alzheimer’s disease. Bioorganic & Medicinal Chemistry 2018; 26 (8): 1511-1522. doi: https://doi.org/10.1016/j.bmc. 2018.01.029
57. Burčul F, Generalić Mekinić I, Radan M, Rollin P, Blažević I. Isothiocyanates: cholinesterase inhibiting, antioxidant, and anti-inflammatory activity. Journal of Enzyme Inhibition and Medicinal Chemistry 2018; 33 (1): 577-582. doi: 10.1080/14756366.2018.1442832
58. Cheung J, Gary EN, Shiomi K, Rosenberry TL. Structures of human acetylcholinesterase bound to dihydrotanshinone I and territrem B show peripheral site flexibility. ACS Medicinal Chemistry Letters 2013; 4 (11): 1091-1096. doi: 10.1021/ml400304w